Michaël Bismuth

2.5k total citations
40 papers, 1.1k citations indexed

About

Michaël Bismuth is a scholar working on Epidemiology, Surgery and Hepatology. According to data from OpenAlex, Michaël Bismuth has authored 40 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Epidemiology, 14 papers in Surgery and 14 papers in Hepatology. Recurrent topics in Michaël Bismuth's work include Liver Disease and Transplantation (11 papers), Liver Disease Diagnosis and Treatment (8 papers) and Iron Metabolism and Disorders (7 papers). Michaël Bismuth is often cited by papers focused on Liver Disease and Transplantation (11 papers), Liver Disease Diagnosis and Treatment (8 papers) and Iron Metabolism and Disorders (7 papers). Michaël Bismuth collaborates with scholars based in France, Switzerland and French Polynesia. Michaël Bismuth's co-authors include Georges‐Philippe Pageaux, Dominique Larrey, Pierre Blanc, Natalie Funakoshi, Françis Navarro, Samir Jaber, Yohan Duny, Jean-Christophe Valats, Stéphanie Faure and Eric Assénat and has published in prestigious journals such as Blood, American Journal of Respiratory and Critical Care Medicine and Gut.

In The Last Decade

Michaël Bismuth

38 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michaël Bismuth France 21 612 559 357 284 178 40 1.1k
Santiago Tomé Spain 18 539 0.9× 578 1.0× 259 0.7× 414 1.5× 135 0.8× 51 1.2k
Thomas E. Starzl United States 15 407 0.7× 273 0.5× 625 1.8× 158 0.6× 265 1.5× 17 1.0k
Satoru Todo United States 13 701 1.1× 523 0.9× 508 1.4× 45 0.2× 80 0.4× 15 1.0k
Yohan Duny France 15 207 0.3× 247 0.4× 151 0.4× 228 0.8× 74 0.4× 20 763
Thomas E. Starzl United States 26 623 1.0× 421 0.8× 1.1k 3.0× 45 0.2× 496 2.8× 48 1.8k
Thomas E. Starzl United States 17 488 0.8× 289 0.5× 867 2.4× 42 0.1× 416 2.3× 27 1.4k
H. H. Neumayer Germany 21 155 0.3× 305 0.5× 365 1.0× 49 0.2× 652 3.7× 54 1.4k
Shohei Fuchinoue Japan 18 143 0.2× 171 0.3× 529 1.5× 58 0.2× 424 2.4× 86 1.1k
Scott Ames United States 17 175 0.3× 254 0.5× 500 1.4× 37 0.1× 522 2.9× 33 1.3k
A. de la Vega Spain 17 536 0.9× 462 0.8× 334 0.9× 18 0.1× 41 0.2× 38 1.0k

Countries citing papers authored by Michaël Bismuth

Since Specialization
Citations

This map shows the geographic impact of Michaël Bismuth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michaël Bismuth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michaël Bismuth more than expected).

Fields of papers citing papers by Michaël Bismuth

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michaël Bismuth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michaël Bismuth. The network helps show where Michaël Bismuth may publish in the future.

Co-authorship network of co-authors of Michaël Bismuth

This figure shows the co-authorship network connecting the top 25 collaborators of Michaël Bismuth. A scholar is included among the top collaborators of Michaël Bismuth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michaël Bismuth. Michaël Bismuth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jeantet, Guillaume, Benjamin Rivière, Natalie Funakoshi, et al.. (2017). Stricturing Crohn’s disease-like colitis in a patient treated with belatacept. World Journal of Gastroenterology. 23(48). 8660–8665. 3 indexed citations
2.
Funakoshi, Natalie, Yohan Duny, Jean-Christophe Valats, et al.. (2015). Systematic review with meta‐analysis: infliximab and immunosuppressant therapy vs. infliximab alone for active ulcerative colitis. Alimentary Pharmacology & Therapeutics. 41(7). 603–612. 39 indexed citations
3.
4.
Funakoshi, Natalie, Gaëlle Tachon, Séverine Cunat, et al.. (2015). The role of genetic factors in patients with hepatocellular carcinoma and iron overload – a prospective series of 234 patients. Liver International. 36(5). 746–754. 13 indexed citations
5.
Assénat, Eric, Stéphanie Faure, Yohan Duny, et al.. (2015). Tacrolimus and the Risk of Solid Cancers After Liver Transplant: A Dose Effect Relationship. American Journal of Transplantation. 15(3). 678–686. 58 indexed citations
6.
Valats, Jean-Christophe, Natalie Funakoshi, P Bauret, et al.. (2013). Covered self-expandable biliary stents for the treatment of bleeding after ERCP. Gastrointestinal Endoscopy. 78(1). 183–187. 10 indexed citations
7.
Flori, Nicolas, Natalie Funakoshi, Yohan Duny, et al.. (2013). Pegylated Interferon-α2a and Ribavirin versus Pegylated Interferon-α2b and Ribavirin in Chronic Hepatitis C. Drugs. 73(3). 263–277. 20 indexed citations
8.
Jung, Boris, Stéphanie Nougaret, Fouad Belafia, et al.. (2012). Pneumonia in Immunocompromised Patients: More than Meets the Eye. American Journal of Respiratory and Critical Care Medicine. 186(11). e18–e18.
9.
Faure, Stéphanie, Astrid Herrero, Boris Jung, et al.. (2012). Excessive alcohol consumption after liver transplantation impacts on long-term survival, whatever the primary indication. Journal of Hepatology. 57(2). 306–312. 103 indexed citations
10.
Bismuth, Michaël, Natalie Funakoshi, Jean–François Cadranel, & Pierre Blanc. (2010). Hepatic encephalopathy. European Journal of Gastroenterology & Hepatology. 23(1). 8–22. 71 indexed citations
11.
Stoebner, P, et al.. (2009). Koebnerizing Kaposi's sarcoma mimics a laparotomic hypertrophic scar in a liver transplant recipient. Liver Transplantation. 15(8). 994–996. 7 indexed citations
12.
Pageaux, Georges‐Philippe, et al.. (2009). Pegylated interferon-α-based treatment for chronic hepatitis C in renal transplant recipients: an open pilot study. Transplant International. 22(5). 562–567. 36 indexed citations
13.
Cunat, Séverine, Muriel Giansily‐Blaizot, Michaël Bismuth, et al.. (2007). Global Sequencing Approach for Characterizing the Molecular Background of Hereditary Iron Disorders. Clinical Chemistry. 53(12). 2060–2069. 26 indexed citations
14.
Perney, Pascal, Michaël Bismuth, Marie‐Christine Picot, et al.. (2005). Are preoperative patterns of alcohol consumption predictive of relapse after liver transplantation for alcoholic liver disease?. Transplant International. 18(11). 1292–1297. 54 indexed citations
15.
Bismuth, Michaël, et al.. (2003). L'hémochromatose héréditaire. La Presse Médicale. 32(36). 1716–1723. 1 indexed citations
16.
Pageaux, Georges‐Philippe, Michaël Bismuth, J Fabré, et al.. (2001). Nocardiosis revealed by thyroid abcess in a liver-kidney transplant recipient. Transplant International. 14(3). 202–204. 12 indexed citations
17.
Aguilar‐Martinez, Patricia, Michaël Bismuth, F Blanc, et al.. (2001). Variable phenotypic presentation of iron overload in H63D homozygotes: are genetic modifiers the cause?. Gut. 48(6). 836–842. 58 indexed citations
18.
Pageaux, Georges‐Philippe, Michaël Bismuth, J Fabré, et al.. (2001). Nocardiosis revealed by thyroid abcess in a liver - kidney transplant recipient. Transplant International. 14(3). 202–204. 17 indexed citations
19.
Mazières, B, et al.. (1986). [Remission of rheumatoid arthritis. Apropos of 32 case reports].. PubMed. 52(7-9). 445–50. 1 indexed citations
20.
Lassoued, Saloua, et al.. (1984). [Association of thrombosis and thrombopenia induced by heparin. Treatment with a low molecular weight heparin].. PubMed. 13(40). 2455–2455. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Santiago Tomé Breakdown of academic impact, for papers by Thomas E. Starzl Breakdown of academic impact, for papers by Satoru Todo Breakdown of academic impact, for papers by Yohan Duny Breakdown of academic impact, for papers by Thomas E. Starzl Breakdown of academic impact, for papers by Thomas E. Starzl Breakdown of academic impact, for papers by H. H. Neumayer Breakdown of academic impact, for papers by Shohei Fuchinoue Breakdown of academic impact, for papers by Scott Ames Breakdown of academic impact, for papers by A. de la Vega
Rankless by CCL
2026